
Plessi-ER 0.75 Tablet
Marketer
Consern Pharma Limited
Salt Composition
Pramipexole (0.75mg)
Overview Plessi-ER 0.75 Tablet
Carbidopa-Levodopa 0.75mg extended-release tablets manage Parkinson's disease symptoms and restless legs syndrome, characterized by an irresistible urge to move legs often due to unpleasant sensations. This medication reduces tremors by regulating movement. Administer this tablet with food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recall; never skip doses, completing the entire course despite symptom improvement. Abrupt cessation is unsafe; consult your doctor before stopping. Potential side effects include nausea, dry mouth, tiredness, visual or auditory disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness may occur; avoid activities demanding concentration until effects are known. Report any unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor immediately, as these can be serious.
Uses of Plessi-ER 0.75 Tablet
Restless legs syndrome and Parkinson's disease
Major Benefits of Plessi-ER 0.75 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Plessi-ER 0.75 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Plessi-ER 0.75 Tablet:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Plessi-ER 0.75 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Plessi-ER 0.75 Tablet with a meal.
How Plessi-ER 0.75 Tablet works:
Plessi-ER 0.75 mg tablets function by replicating the effects of dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Plessi-ER 0.75 mg tablets and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Plessi-ER 0.75 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Plessi-ER 0.75 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant. This medication's prolactin-suppressing effect could negatively impact lactation.
DrivingUNSAFE
Driving ability may be impaired by Plessi-ER 0.75 Tablet, a medication that can induce hallucinations—perceptual distortions such as seeing, hearing, or feeling nonexistent stimuli.
KidneyCAUTION
Patients with kidney impairment should use Plessi-ER 0.75 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Plessi-ER 0.75 Tablet in patients with liver disease appears to present a low risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Plessi-ER 0.75 Tablet :
Omit any missed Plessi-ER 0.75 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Plessi-ER 0.75 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzothiazole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Dopamine-stimulating medications |
